SG/CALL/ASTRAZENECA/10000/0.1/20.12.24 Share Price

Warrant

DE000SU796W2

Market Closed - Börse Stuttgart 11:44:02 28/06/2024 am IST
3.14 EUR -4.56% Intraday chart for SG/CALL/ASTRAZENECA/10000/0.1/20.12.24
Current month+6.08%
1 month+1.95%
Date Price Change
28/24/28 3.14 -4.56%
27/24/27 3.29 -7.06%
26/24/26 3.54 +4.73%
25/24/25 3.38 +4.64%
24/24/24 3.23 +1.89%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 11:44 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SU796W
ISINDE000SU796W2
Date issued 13/02/2024
Strike 10,000 p
Maturity 20/12/2024 (173 Days)
Parity 10 : 1
Emission price 0.87
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.54
Lowest since issue 0.79
Delta0.91x
Omega 4.180
Premium2.77x
Gearing4.58x
Moneyness 1.236
Difference Strike -2,356 p
Difference Strike %-23.56%
Spread 0.19
Spread %5.79%
Theoretical value 3.185
Implied Volatility 26.92 %
Total Loss Probability 12.02 %
Intrinsic value 2.781
Present value 0.4044
Break even 12,698.70 €
Theta-0.02x
Vega0.02x
Rho0.05x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
156.2 USD
Average target price
174.4 USD
Spread / Average Target
+11.69%
Consensus